PATENT CLAIM ANALYSIS

Application Number: 16227099
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "182000"]

Abstract:
Compounds are provided according to Formula (I): Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, wherein R 1 , R 2 , R 3 , R 6 , R 7 , R 8 , and n are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Claim (Index 12):
The compound of  claim 5 , wherein R 2  is C 1-6  alkyl and R 3  is C 1-6  alkyl.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.62791
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15742425', '15721393', '14785175', '15742422', '15660114']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7683875250611711
- 35 USC 102 Novelty (BERT): 0.5402170436711972
- Combined Prediction Score: 0.7455704769221738
- Mean Citation Score: 345.709976
- Max Citation Score: 355.96622
- Similarity Product: 201.5878836885643

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test